Kathryn A. Grenier

AmpliMed Corp. develops and manufactures drugs to treat cancer. Its products include amplimexon, amplizone and benzimidazole series. The firm is focused on the development of small-molecule oncology drugs with novel mechanisms of action. The company was founded by Evan M. Hersh, David S. Alberts, Robert Thomas Dorr and William A. Remers in 1989 and is headquartered in Tucson, AZ.

Somnus Medical Technologies, Inc. designs, develops, manufactures, and markets medical devices. Its products utilizes proprietary temperature-controlled radiofrequency technology for the treatment of upper airway disorders in a procedure called somnoplasty. The company was founded on April 9, 1996 and is headquartered in Sunnyvale, CA.

Gyrus Group Ltd. designs, develops, manufactures and markets electro-surgical systems. It operates in four segments: surgical, urology, gynaecology, ent, and partnered technologies. The firm supplies medical devices which reduce trauma and complications in surgery and develops tissue management systems, instruments and services. Gyrus Group was founded in 1989 and is headquartered in London, the United Kingdom.

Part of Becton, Dickinson & Co., Becton Dickinson Immunocytometry Systems manufactures medical instruments. The company is based in San Jose, CA.

Part of University of Arizona, Arizona Cancer Center provides clinical and medical research services. The company is based in Tucson, AZ.

Cancer Prevention Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of therapeutic agents for the treatment and prevention of certain pre-cancerous conditions, orphan diseases and gastrointestinal conditions. The company’s pipeline consists of Gastrointestinal and Orphan. Cancer Prevention Pharmaceuticals was founded by Dr. Frank Meyskens and Gene Gerner in June 9, 2008 and is headquartered in Tucson, AZ.